Defibrotide for the Treatment of Severe COVID-19

Abroad (travel likely)RecruitingPHASE2

Conditions

Covid19

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Paul G Richardson, MD) · Paul_Richardson@dfci.harvard.edu · 617-632-2127
Contact: Principal Investigator (Paul G Richardson, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

COVID19 · Influenza Vaccination · ACE Inhibitors

Abroad (travel likely)Recruiting

Terrassa, Spain

KIDney Injury in Times of COVID-19 (KIDCOV)

SARS-CoV Infection · Covid19 · Corona Virus Infection

Abroad (travel likely)Recruiting

San Francisco, United States · Chicago, United States

Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19

Lung Function · Exercise Capacity · Quality of Life

Abroad (travel likely)Recruiting

Hong Kong, Hong Kong